Snapshots from the Edge: Key Lessons for AI in Drug Discovery from Early Cloudification in Life Sciences

“When people hear AI they assume, ‘ChatGPT is sometimes wrong, so we shouldn’t use it at all.’ But you can tell the story in a different way, and explain how we’re really doing the same things, but at a greater speed, and there’s still going to be the human intervention.”

GT LifeScience CTO John Harris revisits the early days of cloudification in life sciences, and its critical lessons for secure and productive AI implementation in drug discovery today.